Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.

Cancer - 15 Nov 2003

Morimoto Yuki, Ozaki Toshifumi, Ouchida Mamoru, Umehara Norifumi, Ohata Norihide, Yoshida Aki, Shimizu Kenji, Inoue Hajime

Abstract excerpt

BACKGROUND: A recent study revealed that single nucleotide polymorphism (SNP) at codon 388 (Gly or Arg) of fibroblast growth factor receptor 4 (FGFR4) was associated with prognosis in patients with carcinoma of the breast and colorectal carcinoma. The purpose of the current study was to investiga...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Neoplasms
Share to Codon
Share to Neoplasm Metastasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptor, Fibroblast Growth Factor, Type 4

Share to Receptors, Fibroblast Growth Factor

Share to Sarcoma

Share to Soft Tissue Neoplasms

Share to Survival Analysis

Source

Identifiers

PMID: 14601095
DOI: 10.1002/cncr.11778

Genes

FGFR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-14601095-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Single nucleotide polymorphism in fibroblast growth factor receptor 4 at codon 388 is associated with prognosis in high-grade soft tissue sarcoma.PMID 14601095Read ↗

The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.Semantic proximity Read ↗

FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.Semantic proximity Read ↗

The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis.Semantic proximity Read ↗

Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.Semantic proximity Read ↗

Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.Semantic proximity Read ↗

Is FGFR4 Gly388Arg missense variant a suitable prognostic marker in neuroblastoma?Semantic proximity Read ↗

Functional FGFR4 Gly388Arg Polymorphism Predicts Prognosis in Lung Adenocarcinoma PatientsSemantic proximity Read ↗

FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.Semantic proximity Read ↗

Single nucleotide polymorphism of hsa-miR-124a affects risk and prognosis of osteosarcoma.Semantic proximity Read ↗

Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer.Semantic proximity Read ↗

Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.